Everest Medicines Ltd. (1952) Cash flow

4 Followers

Everest Medicines Ltd. Cash Flow

HK:1952's free cash flow for Q2 2025 was ¥-102.92M. For the 2025 fiscal year, HK:1952's free cash flow was decreased by ¥572.60M and operating cash flow was ¥-90.74M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	¥ -109.96M	¥ -679.51M	¥ -769.19M	¥ -1.16B	¥ -729.94M
Investing Cash Flow	¥ -674.78M	¥ 974.40M	¥ 752.50M	¥ -1.03B	¥ -975.82M
Financing Cash Flow	¥ 1.75B	¥ 37.80M	¥ 10.10M	¥ -25.31M	¥ -76.51M
End Cash Position	¥ 2.73B	¥ 884.47M	¥ 523.06M	¥ 490.79M	¥ 2.64B
Free Cash Flow	¥ -172.32M	¥ -744.92M	¥ -1.04B	¥ -1.59B	¥ -1.71B

Currency in CNY